Free-cash-flow proxy increased 23.6%
Free-cash-flow proxy changed +23.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$107.0M→-$81.7M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ALMS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 23.4%
Operating cash flow changed +23.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$106.4M→-$81.5M3 prior comparisons
Operating margin moved 368485 bp lower
Operating margin changed -368485 basis points from the comparable as-filed period.
-5271.53%→-8956.38%0 prior comparisons
Revenue decreased 37.7%
Revenue changed -37.7% from the comparable as-filed period.
$2.7M→$1.7M0 prior comparisons
Cash & equivalents decreased 58.0%
Cash & equivalents changed -58.0% from the comparable as-filed period.
$151.8M→$63.7M2 prior comparisons
Research & development decreased 21.5%
Research & development changed -21.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$108.8M→$85.3M2 prior comparisons
Stock-based compensation decreased 23.4%
Stock-based compensation changed -23.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$18.6M→$14.3M2 prior comparisons
Capex / revenue moved 885 bp lower
Capex / revenue changed -885 basis points from the comparable as-filed period.
23.11%→14.26%0 prior comparisons
Capital expenditure decreased 61.5%
Capital expenditure changed -61.5% from the comparable as-filed period.
$616,000→$237,0003 prior comparisons
Operating income decreased 5.9%
Operating income changed -5.9% from the comparable as-filed period.
-$140.5M→-$148.9M2 prior comparisons
SBC / revenue moved 15980 bp higher
SBC / revenue changed +15980 basis points from the comparable as-filed period.
698.99%→858.78%0 prior comparisons
Current liabilities decreased 10.9%
Current liabilities changed -10.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$85.6M→$76.2M3 prior comparisons
Working capital / assets moved 739 bp higher
Working capital / assets changed +739 basis points from the comparable as-filed period.
70.71%→78.10%3 prior comparisons
Total assets decreased 8.2%
Total assets changed -8.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$610.9M→$560.6M3 prior comparisons
Operating cash-flow margin moved 91453 bp lower
Operating cash-flow margin changed -91453 basis points from the comparable as-filed period.
-3989.20%→-4903.73%0 prior comparisons
R&D / revenue moved 105526 bp higher
R&D / revenue changed +105526 basis points from the comparable as-filed period.
4079.33%→5134.60%0 prior comparisons
Free-cash-flow margin moved 90569 bp lower
Free-cash-flow margin changed -90569 basis points from the comparable as-filed period.
-4012.30%→-4917.99%0 prior comparisons
Current assets decreased 0.7%
Current assets changed -0.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$517.6M→$514.1M3 prior comparisons
Working capital increased 1.4%
Working capital changed +1.4% from the comparable as-filed period.
$432.0M→$437.9M3 prior comparisons
Current ratio increased 11.5%
Current ratio changed +11.5% from the comparable as-filed period.
6.05→6.743 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.